Research: Bile Acid Sequestrant Reduces Glucose Concentration in T2DM

gt06

For patients with type 2 diabetes taking metformin monotherapy, the bile acid sequestrant colesevelam reduces fasting and postprandial glucose concentrations without any effects on insulin concentration, secretion, or action.

Read more

Posted in Medical Research Type II